Genome-scale CRISPR-Cas9 screen identifies novel host factors as potential therapeutic targets for SARS-CoV-2 infection. https://www.biorxiv.org/content/10.1101/2023.03.06.531431v1?med=mas
Genome-scale CRISPR-Cas9 screen identifies novel host factors as potential therapeutic targets for SARS-CoV-2 infection. https://www.biorxiv.org/content/10.1101/2023.03.06.531431v1?med=mas